Synaptogenix Inc
NASDAQ:SNPX
Synaptogenix Inc Stock, NASDAQ:SNPX
1185 Avenue of the Americas, 3rd floor, New York, New York 10036
Phone: +1.973.242.0005
Number of Employees:
Description
Synaptogenix, Inc. operates as a biopharmaceutical company. It develops a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer�s disease, which is in the clinical testing stage. The firm also evaluates potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions. The company was founded on October 31, 2012 and is headquartered in New York, NY.